Dan Brennan
Stock Analyst at TD Cowen
(4.45)
# 291
Out of 5,072 analysts
120
Total ratings
56.84%
Success rate
18.45%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.68 | +90.22% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $403.42 | -3.33% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $101.29 | -11.15% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $7.63 | +17.96% | 2 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Hold | $40 → $42 | $48.81 | -13.95% | 2 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Hold | $110 → $115 | $131.45 | -12.51% | 13 | Oct 31, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $590.83 | +10.69% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $226.78 | +14.65% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $153.50 | +5.54% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $108.42 | -33.59% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $12.10 | -0.83% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $19.66 | -23.70% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $25.49 | +25.54% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $166.95 | -34.11% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.62 | -30.94% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $77.93 | -5.04% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $238.81 | -26.72% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $178.14 | +40.34% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $104.41 | +37.92% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $11.73 | +164.28% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $41.11 | +24.06% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $8.17 | +585.43% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $18.81 | +70.12% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $184.18 | +196.45% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.32 | +546.55% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $185.00 | +25.41% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,476.72 | -40.41% | 3 | Oct 7, 2020 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.68
Upside: +90.22%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $403.42
Upside: -3.33%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $101.29
Upside: -11.15%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $7.63
Upside: +17.96%
Bruker
Nov 4, 2025
Maintains: Hold
Price Target: $40 → $42
Current: $48.81
Upside: -13.95%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $110 → $115
Current: $131.45
Upside: -12.51%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $590.83
Upside: +10.69%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $226.78
Upside: +14.65%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $153.50
Upside: +5.54%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $108.42
Upside: -33.59%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $12.10
Upside: -0.83%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $19.66
Upside: -23.70%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $25.49
Upside: +25.54%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $166.95
Upside: -34.11%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.62
Upside: -30.94%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $77.93
Upside: -5.04%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $238.81
Upside: -26.72%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $178.14
Upside: +40.34%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $104.41
Upside: +37.92%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $11.73
Upside: +164.28%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $41.11
Upside: +24.06%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $8.17
Upside: +585.43%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $18.81
Upside: +70.12%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $184.18
Upside: +196.45%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.32
Upside: +546.55%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $185.00
Upside: +25.41%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,476.72
Upside: -40.41%